Alcobra Ltd. Announces New Findings on Diminished Abuse Potential of Its Proprietary Drug Candidate, MG01CI

Published November 22, 2013

Alcobra Ltd. Announces New Findings on Diminished Abuse Potential of Its Proprietary Drug Candidate, MG01CI
TEL AVIV, Israel — Alcobra Ltd. (the "Company"), an emerging biopharmaceutical company primarily focused on the development and commercialization of its proprietary drug candidate, MG01CI (Metadoxine … Drug Abuse – Yahoo News Search Results